Daphne Zohar

Daphne Zohar is an American entrepreneur. She is the founder and CEO of PureTech, a Healthcare company developing medicines at the interface of the brain, gut and immune system. PureTech went public in June 2015, raising $196 million.

She was named to the MIT Technology Review TR35 as one of the top innovators in the world under the age of 35.[1] In 2010 she was selected by BioWorld, a widely read biotechnology industry publication, as one of 28 leaders predicted to be the "movers and shakers" of the biotechnology industry over the next twenty years.[2] That same year, Zohar was also featured as one of “The Boston Area’s Top 15 Innovators” by The Boston Globe.[3][4] In 2011, Zohar was named one of Boston Business Journal’s “Women to Watch,”[5] in 2012 she was named one of the most powerful female voices in healthcare innovation and on Twitter by MedCity News,[6] and in 2013, Scott Kirsner of The Boston Globe named Zohar one of the 10 most influential women in biotech.[7]

PureTech and Zohar are also known for development of technologies together with strategic partners.[8][9][10][11]

Zohar has also been vocal in criticizing the venture industry for its treatment of entrepreneurs.[12]

References

  1. ↑ "2003 Innovators Under 35". MIT Technology Review. 2003. Retrieved August 15, 2011.
  2. ↑ "The Future is Here: Who Will Shape Biotech Over the Next 20 Years? Bioworld Says..." (PDF). BioWorld 20th Anniversary Edition. 2010.
  3. ↑ Kirsner, Scott (2010). "The Boston area's top 15 innovators". The Boston Globe.
  4. ↑ Meghna Chakrabarti and Anthony Brooks (October 11, 2010). "Massachusetts Tech Innovators Recognized". WBUR Radio Boston.
  5. ↑ Gambon, Jim (March 15, 2011). "2011 Women to Watch: Daphne Zohar". Boston Business Journal.
  6. ↑ Pogorelc, Deanna (October 9, 2012). "These 12 women are powerful voices both in healthcare innovation and on Twitter". MedCity News.
  7. ↑ Kirsner, Scott (September 15, 2013). "The 10 most influential women in biotech". The Boston Globe.
  8. ↑ Singer-Vine, Jeremy (July 10, 2008). "Big Pharmas Join to Speed Discoveries". The Wall Street Journal.
  9. ↑ McBride, Ryan (June 15, 2009). "Novartis Backing Enlight Biosciences". Xconomy.
  10. ↑ Mack, George S. (2008). "Pharmas partner in venture seeking drug discovery tools". Nature.
  11. ↑ "Enlight Bioscience – Collaborating to Improve the Drug Discovery Process". Merck.
  12. ↑ Zohar, Daphne (August 24, 2009). "Venture Model Makeover & Diet Plan – Step One". Xconomy.

External links

This article is issued from Wikipedia - version of the 11/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.